GlassScriptPhysician profile
Allie L Cherfan
NPI 1114145430
$572.20
in general payments reported to CMS, 2019-2025
13 companies · $36.77 in 2025
The $36.77 reported for 2025 was less than what a typical Emergency Medicine provider received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $96.22 · 2020: $121 · 2021: $37.81 · 2022: $98.72 · 2023: $58.02 · 2024: $123 · 2025: $36.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $218.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $215.36 | 2019-2025 | Wegovy |
| Abbvie INC. | $136.67 | 2019-2020 | |
| Therapeuticsmd, INC. | $33.24 | 2020-2021 | |
| Hologic Sales and Service, LLC | $26.07 | 2024 | Acessa Provu System |
| Sumitomo Pharma America, INC. | $23.18 | 2025 | Myfembree |
| Lupin INC. | $22.10 | 2019-2020 | |
| Exeltis, USA INC. | $20.33 | 2021 | |
| Merck Sharp & Dohme LLC | $20.33 | 2023 | Gardasil 9 |
| Alkermes, INC. | $17.80 | 2023 | Vivitrol |
| Eisai INC. | $16.34 | 2019 | |
| Bausch Health US, LLC | $16.16 | 2022 | |
| Scynexis, INC. | $12.55 | 2022 | |
| Mylan Pharmaceuticals INC. | $12.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allie Cherfan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.